Wilmington Trust National Association’s Bristol-Myers Squibb BMY Stock Holding History

Wilmington Trust National Association’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$22.7M	Sell	466,963 -100,999	-18%	-$4.98M	0.78%	27
2014 Q1	$29.5M	Sell	567,962 -5,847	-1%	-$311K	1.08%	19
2013 Q4	$30.5M	Sell	573,809 -1,687	-0.3%	-$85.9K	1.12%	19
2013 Q3	$26.6M	Buy	575,496 +13,290	+2%	+$583K	1.07%	19
2013 Q2	$25.1M	Buy	+562,206	New	+$24.4M	1.09%	19

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wilmington Trust National Association's BMY Position: Q2 2014 in Review

Wilmington Trust National Association reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2014, selling an estimated $4.98M and leaving 466,963 shares worth $22.7M. The position accounts for 0.78% of the portfolio, ranked #27.

Wilmington Trust National Association first reported a position in BMY in Q2 2013 and has held it in 5 quarters since. The position peaked at $30.5M in Q4 2013. 1,302 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

Wilmington Trust National Association held 466,963 shares of Bristol-Myers Squibb worth $22.7M as of Q2 2014.
Wilmington Trust National Association sold 100,999 Bristol-Myers Squibb shares in Q2 2014, an estimated $4.98M.
Bristol-Myers Squibb made up 0.78% of Wilmington Trust National Association's portfolio in Q2 2014, its #27 holding.
Wilmington Trust National Association first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 5 quarters since.
Wilmington Trust National Association's Bristol-Myers Squibb position peaked at $30.5M in Q4 2013.
1,302 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Wilmington Trust National Association's 13F filing for Q2 2014, filed 13 Aug 2014.